Terms: = Ovarian cancer AND NCOR1, hCIT529I10, 9611, ENSG00000141027, N-CoR, MGC104216, TRAC1, O75376, hN-CoR, KIAA1047
3 results:
1. Homologous recombination deficiency in diverse cancer types and its correlation with platinum chemotherapy efficiency in ovarian cancer.
Wen H; Feng Z; Ma Y; Liu R; Ou Q; Guo Q; Shen Y; Wu X; Shao Y; Bao H; Wu X
BMC Cancer; 2022 May; 22(1):550. PubMed ID: 35578198
[TBL] [Abstract] [Full Text] [Related]
2. Difference between genomic actions of estrogen versus raloxifene in human ovarian cancer cell lines.
Sasaki H; Hayakawa J; Terai Y; Kanemura M; Tanabe-Kimura A; Kamegai H; Seino-Noda H; Ezoe S; Matsumura I; Kanakura Y; Sakata M; Tasaka K; Ohmichi M
Oncogene; 2008 Apr; 27(19):2737-45. PubMed ID: 18193094
[TBL] [Abstract] [Full Text] [Related]
3. Relationship between expression of coactivators and corepressors of hormone receptors and resistance of ovarian cancers to growth regulation by steroid hormones.
Havrilesky LJ; McMahon CP; Lobenhofer EK; Whitaker R; Marks JR; Berchuck A
J Soc Gynecol Investig; 2001; 8(2):104-13. PubMed ID: 11336882
[TBL] [Abstract] [Full Text] [Related]
